OverviewChartProfileKey statisticsFinancialsNewsTraderScreen

BBI BUERG.BRAUH.IMMO./  DE0005280002  /

Frankfurt
2024-04-23  8:04:14 AM Chg. +0.7500 Volume Bid8:04:15 AM Ask8:04:15 AM Market Capitalization Dividend Y. P/E Ratio
8.4000EUR +9.80% 0
Turnover: 0.0000		 8.4000Bid Size: 50 9.0000Ask Size: 50 43.68 mill.EUR 8.81% -
GlobeNewswire 04-09 SMX Announces Partnership with Torchlight AI
GlobeNewswire 2023-11-15 Global Bioenergies strengthens its cash position thanks to several cash inflows coming from public f...
GlobeNewswire 2023-08-28 Esperion to Participate in H.C. Wainwright 25th Annual Global Investment Conference
Newsfile Corp 2022-08-24 Introducing DuraTech(TM) by Microban(R): a Non-Heavy Metal Antimicrobial Cotton Technology with Supe...
GlobeNewswire 2022-03-15 Brickell Biotech Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate ...
GlobeNewswire 2022-03-10 Brickell Biotech Selected for a Late-Breaking Oral Presentation of US Phase 3 Pivotal Cardigan I and...
GlobeNewswire 2022-03-09 New Developments on Dominica’s Geothermal Project Include International Contract, New Wells
GlobeNewswire 2022-03-08 Brickell Biotech to Report Fourth Quarter and Full Year 2021 Financial Results and Provide a Corpora...
GlobeNewswire 2022-02-02 Brickell Biotech Acquires Exclusive Global Rights to Portfolio of Novel STING Inhibitors Targeting A...
GlobeNewswire 2021-11-09 Brickell Biotech Reports Third Quarter 2021 Financial Results and Provides Corporate Update
GlobeNewswire 2021-11-01 Brickell Biotech to Report Third Quarter 2021 Financial Results and Provide a Corporate Update on No...
GlobeNewswire 2021-10-28 Brickell Biotech Prices Public Offering of Common Stock
GlobeNewswire 2021-10-27 Brickell Biotech Announces Proposed Underwritten Public Offering of Common Stock
GlobeNewswire 2021-10-07 Brickell Biotech Announces Positive Topline Results, Achieving Statistical Significance on all Prima...
GlobeNewswire 2021-09-30 Clearcover Partners with Zendrive and Cover to Acquire Safe Drivers with Insurance Qualified Leads (...
GlobeNewswire 2021-09-17 Brickell Biotech to Host Key Opinion Leader Webinar on DYRK1A and its Role in Autoimmunity
GlobeNewswire 2021-09-08 Brickell Biotech to Participate at Upcoming September Conferences
GlobeNewswire 2021-09-01 Brickell Biotech Expands Leadership Team, Appointing Dr. Monica Luchi as Chief Medical Officer
GlobeNewswire 2021-09-01 Brickell Biotech Acquires Exclusive Rights to Phase 1-Ready DYRK1A Inhibitor Program and Novel Platf...
GlobeNewswire 2021-08-31 ORION BIOTECHNOLOGY ADDS INDUSTRY LEADER TO BOARD OF DIRECTORS
GlobeNewswire 2021-08-16 Brickell Biotech Announces Final Patient Completed Second U.S. Phase 3 Pivotal Clinical Study of Sof...
GlobeNewswire 2021-08-12 Brickell Biotech Reports Second Quarter 2021 Financial Results and Provides Corporate Update
GlobeNewswire 2021-07-29 Brickell Biotech to Report Second Quarter 2021 Financial Results and Provide a Corporate Update on A...
GlobeNewswire 2021-07-22 Brickell Biotech Announces Closing of $8.05 Million Bought Deal Offering of Common Stock, Including ...
GlobeNewswire 2021-07-20 Brickell Biotech Increases Previously Announced Bought Deal Offering of Common Stock to $7.0 Million